Phathom Pharmaceuticals, Inc. (PHAT)

Phathom Pharmaceuticals Revenue

Phathom Pharmaceuticals had revenue of $28.52M in the quarter ending March 31, 2025, with 1,391.58% growth. This brings the company's revenue in the last twelve months to $81.86M, up 3,055.71% year-over-year. In the year 2024, Phathom Pharmaceuticals had annual revenue of $55.25M with 8,001.47% growth.

• Revenue (ttm): $81.86M
• Revenue Growth: +3,055.71%
• P/S Ratio: 7.08
• Revenue / Employee: $191,707
• Employees: 427
• Market Cap: 606.64M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	55.25M	54.57M	8,001.47%
Dec 31, 2023	682.00K	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.